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The role of DNA methylation in thermogenic adipose biology
Han Xiao and Sona Kang
Department of Nutritional Sciences and Toxicology, UC Berkeley, Berkeley, CA, USA
ABSTRACT
The two types of thermogenic fat cells, beige and brown adipocytes, play a significant role in
regulating energy homeostasis. Their development and thermogenesis are tightly regulated by
dynamic epigenetic mechanisms, which could potentially be targeted to treat metabolic disorders
such as obesity. However, we are just beginning to catalog and understand these dynamic
changes. In this review, we will discuss the current understanding of the role of DNA (de)
methylation events in beige and brown adipose biology in order to highlight the holes in our
knowledge and to point the way forward for future studies.
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Introduction
At least three types of adipose tissue exists in mam-
mals: white, beige, and brown [1,2]. White adipo-
cytes store excess energy as triglycerides and release
them as needed, whereas brown adipocytes burn that
energy to create heat [1,2]. Beige adipocytes sit
between the two phenotypes, seemingly alternating
between storing energy and burning it [1,2]. In
rodents, classical brown adipose tissue exists in
defined anatomical depots, such as the interscapular
regions [1,2]. Concordantly, human studies detect
thermogenic adipocytes around the neck, clavicle
and spinal cord [3–7] that burn glucose and fatty
acids [8,9]. Beige adipocytes aren’t in depots, but
instead, are interspersed within white adipose tissue
(WAT) [10].
For thermogenesis, both beige and brown adipo-
cytes have abundant mitochondria to oxidize fatty
acids, thus generating heat via uncoupling protein 1
(UCP1)-dependent and independent mechanisms
[10,11]. Beige adipocytes biogenesis in WAT is
induced by various environmental cues, including
cold exposure, exercise, and PPARγ agonist [12,13],
in a process called ‘browning’ or ‘beiging’[14].
Conversely, they undergo ‘whitening’ in response
to thermoneutrality, impaired β-adrenergic signal-
ing, lipase deficiency, and other cues [15]. Brown
adipocytes also exhibit a certain degree of flexibility
in their thermogenic gene program and morphology
[16,17]. Because chronic cold acclimatization in
humans leads to increased adipose thermogenic
activity, which leads to increased energy expenditure
[18,19], beige and brown adipocytes are an attractive
therapeutic target for obesity and related metabolic
diseases [19–21].
Studies strongly suggest that DNA (de)methyla-
tion plays a critical role in thermogenic adipose
development and gene regulation. The reversible
nature of epigenetic changes raises hope for ther-
apeutic interventions that can reverse deleterious
epigenetic programing as a means to prevent or
treat relevant metabolic disorders. However,
a deeper understanding is needed before medical
therapies can be developed to target the epigen-
ome. Here, we will discuss the current understand-
ing of the role of DNA (de)methylation events in
beige and brown adipose biology, with a focus on
their development and gene regulation.
DNA (De)methylation in brown adipogenesis
PR domain–containing 16 protein (PRDM16) is
a key developmental transcriptional regulator that
commits progenitors to the brown adipogenic line-
age and maintains brown adipocyte identity [22].
Prdm16 is enriched with CpG sites around its tran-
scription start site, and hypomethylation at three
specific regions of its promoter, likely mediated by
the TET proteins, leads to increased Prdm16
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expression during brown adipogenesis [23,24].
Moreover, reducing the level of α-ketoglutarate
(αKG), a co-factor for the TET enzymes, leads to
reduced demethylation of Prdm16 and impaired
brown adipocyte development and function in
mutant mice carrying loss-of-function of
AMPKa1 [23].
To find loci important for brown adipose develop-
ment, two independentDNAmethylome studies were
conducted to identify differentiallymethylated regions
between white and brown adipocytes. The first study
differentiated stromal vascular cells into inguinal and
brown adipose cells in vitro [25]. The authors found
that white adipogenesis has more hypermethylation
overall than brown adipogenesis, and it is located
mostly at intronic and intergenic regions. On the
other hand, brown adipocytes have hypomethylated
exonic regions that are significantly enriched for genes
involved in brown fat functions such as themitochon-
drial respiratory chain and fatty acid oxidation [25].
Notably, several Hox transcription factors are
differentially methylated, some of which are linked
to adipogenesis and diabetes [26,27]. For example,
Hoxc9 is a well-established adipocyte marker [28],
and Hoxc9 and Hoxc10 promoter methylation is
inversely correlated with their gene expression in
brown adipose tissue.
The second global study compared the DNA
methylation profile of primary white vs. brown
pre-adipocytes, among other cell types. Here,
authors concluded that the DNA methylome is
greatly similar between white and brown adipo-
cytes [29]. However, there are multiple variables
that could account for the discrepancy, including
the cell types used (in vitro differentiated vs. pri-
mary cells), differential genome coverages due to
the profiling method (reduced representation
bisulfite sequencing vs. restriction hallmark geno-
mic scanning), and the number of comparative
analyses (two cell types vs. multiple comparisons
between multiple cell types). Future genome-wide
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Figure 1. Summary of external stimuli and DNA (de)methylation machinery and events that affect thermogenic adipose biology.
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are needed to compare, at base-pair resolution, the
DNA methylation events between white and
brown adipogenesis.
There are likelymany regions involved in thermo-
genic adipogenesis that are controlled epigenetically,
as global inhibition of (de)methylation greatly
impacts general adipogenesis. The expression of
TETs, the mediators of DNA demethylation, is upre-
gulated in tissue culture models of both white and
brown adipogenesis [23,30]. In addition, TET1
appears to use a physical interaction with a nuclear
receptor (PPARγ) to target adipose genes during
differentiation [31,32]. This results in demethylation
and H3K4me1/H3K27ac around PPARγ binding
sites in 3T3-L1 adipocytes [31–33]. Interestingly, in
mature adipocytes, TET2 facilitates the transcrip-
tional activity of PPARγ and the insulin-sensitizing
efficacy of PPARγ agonist by sustaining PPARγ
DNA binding at certain target loci [34]. These stu-
dies employed non-brown/beige adipocyte cell lines,
yet it is likely that the TETs play additional roles in
thermogenic adipocytes – outside of their effect on
Prdm16. These roles require further studies using
beige and brown adipocyte models.
Opposing the TETs are DNMTs, the mediators of
DNA methylation. No specific role in brown adipo-
genesis has been found for DNMTs; however, they
are likely important, as they have huge effects on
general adipogenesis. Pharmacological and genetic
inhibition of DNMTs appears to have biphasic
impact on adipogenesis. Administering DNMT inhi-
bitor prior to or during the early stages of adipogen-
esis enhanced adipogenesis [35–38]. This holds true
in multiple tissue culture models including multi-
potent C3H10T1/2, ST2 cells, and pre-white adipo-
cytes 3T3-L136–[38]. However, the opposite effect is
observed when the inhibitor is added at a later stage
of differentiation [39]. Knockdown of Dnmt1 and
Dnmt3a during clonal expansion or early adipogen-
esis (day 0–2) impairs 3T3-L1 adipogenesis [39–41]
but promotes lipid accumulation when knocked
down on day 5 [39].
The specific effect of these DNMTs may depend
on their expression pattern. Dnmt1 expression is
transiently increased during the mitotic clonal
expansion phase [42], which is critical for in vitro
adipogenesis [43], and reduced in later stages of
differentiation [42]. By contrast, Dnmt3a expression
is increased during later stages of adipogenesis, while
Dnmt3b expression remains low and relatively stable
during differentiation. Together, these studies sug-
gest that DNAmethylation, along with DNMT1 and
3a, has complex roles in adipogenesis depending on
the stage of adipose conversion. However, another
group reported that DNMT1 is anti-adipogenic even
during early phases by showing that DNMT1 is
necessary for maintaining DNA methylation and
repressive H3K9 histone methylation at key adipo-
genic genes, such as Pparg, during clonal expansion
[42]. Such a discrepancy might be due to the knock-
down efficiency of Dnmt1 or tissue culture variables
between the two laboratory environments. While it
is likely that DNMTs play a role in brown adipogen-
esis, future studies are necessary to reveal their exact
functional role.
DNA methylation in brown adipocyte gene
regulation
UCP1 is important for adipocyte thermogenesis, as
it uncouples the respiratory chain, allowing for fast
substrate oxidation with a low rate of ATP produc-
tion. Brown adipocyte-specific Ucp1 expression is
associated with reduced CpG methylation at the
Ucp1 enhancer and can be further reduced by
DNMT inhibitor in brown adipocyte HIB1B cells
[44]. Moreover, cold adaptation causes DNA
hypomethylation at the CpG sites within two of
the cyclic AMP response elements in the Ucp1
promoter [44]. Consistent with this, under cold
conditions, the Ucp1 locus is more enriched in
the active histone mark (H3K4me3) in brown adi-
pose tissue (BAT), whereas the repressive mark
(H3K9me2) is enriched in white adipose tissue
(WAT) [44].
Peroxisome proliferator–activated receptor
gamma coactivator 1 alpha (PGC-1α) is required
for the cold-inducible expression of Ucp1 [45].
PGC-1α is a transcriptional co-activator that regu-
lates genes involved in energy metabolism, and its
methylation changes in the context of insulin resis-
tance and exercise in tissues like skeletal muscle
[46,47]. However, whether temperature changes
cause changes in Ppargc1a methylation in beige
and brown adipocytes remains to be uncovered.
Another study suggests that DNA methylation is
involved in the brown adipocyte–specific expression
of Vaspin (visceral adipose tissue–derived serine
EPIGENETICS 839
protease inhibitor; SERPINA12). Vaspin is an adi-
pokine suggested to be anti-diabetic and anti-
obesogenic [48] because it inhibits hepatic gluconeo-
genesis and improves insulin signal transduction
[49–51]. A microarray study found that Vaspin
level is strongly upregulated in BAT after cold expo-
sure, and another study found that Vaspin promoter
regions in BAT are more hypomethylated than white
adipose depots in mice fed with normal chow.
Moreover, acute cold exposure further decreases
methylation levels, notably at one CpG site (CpG-
525). Supporting the in vivo findings, in vitro experi-
ments demonstrate that vaspin mRNA expression is
markedly upregulated after treating BAT pre-
adipocytes with the DNMT inhibitor 5-aza-2ʹ-
deoxycytidine for 48h prior to differentiation.
Future studies are warranted to address the causal
role of DNA methylation in brown adipose–specific
gene regulation in response to various physiological
stimuli.
DNA methylation in intergenerational and
transgenerational brown adipocyte function
Intergenerational effects occur when the parental
environment (F0) directly affects their germ cells or
developing fetus (F1). A true transgenerational effect
can only be proven if the effect of exposure is trans-
mitted to the F2 (when parental exposure occurred
before conception) or F3 (when maternal exposure
occurred during pregnancy) [52]. Accumulating evi-
dence supports that DNA methylation plays an
important role in the heritability of obesity and
other metabolic disorders. A classic example is the
Agouti (Avy) mouse model. Ectopic expression of the
Agouti gene during development, due to hypomethy-
lation of the cryptic promoter, results in agouti fur, as
well as adult-onset obesity, diabetes, and tumorigen-
esis [53]. The tendency for obesity is exacerbated
when the Avy allele comes from an obese Avy mother
[54], and this intergenerational effect is partially
reversed by supplementing with methyl-donors,
which promote DNA hypermethylation [54]. In addi-
tion, in humans, several genes important for develop-
ment and metabolism, such as IGF2 and LEP, are
differentially methylated in newborns that were pre-
natally exposed to famine and overnutrition [55,56].
A recent study revealed the link between DNA
methylation and the intergenerational impact of
environmental exposure on brown adipose activity
[57]. Notably, cold exposure in males, but not
females, prior to conception results in increased
cold tolerance and improved whole-body metabo-
lism in male offspring in association with
enhanced expression of UCP1 in BAT [57]. This
intergenerational transmission is associated with
altered DNA methylation at multiple genomic
loci within the sperm – most prominently in the
gene body of Adrb3, which encodes a protein that
mediates β-adrenergic stimulation in BAT, was
hypomethylated in sperm [57]. This led to
increased expression of Adrb3 in inguinal, epidi-
dymal, and BAT of the cold exposed offsprings
[57]. This study supports the possibility that
DNA methylation underlies the epigenetic basis
of the sexually dimorphic inheritance of prenatal
cold exposure.
Another intriguing study showed that neonates
born to obese wild-type mice have reduced brown
adipose activity [23], a finding that is correlated with
obesity [19,58]. These mice have reduced Prdm16
expression, in association with a reduced α-KG
level, due to DNA hypermethylation at Prdm16
[23]. As a result, Ucp1 expression is reduced in
these offspring, impairing the ability to maintain
body temperature in response to cold [23].
Interestingly, administering AMPK agonists, like
metformin and AICAR, which increase α-KG level
by activating AMPK-dependent signaling pathways
after birth, rescues the inherited obesity-induced
suppression of brown adipogenesis and adaptive
thermogenesis in offspring [23]. Consistent with
this mouse study, a human study reported that
maternal obesity increases DNA methylation in the
Prdm16 promoter in the placenta at birth [59].
Zinc-finger protein 423 (Zfp423) is a preadipocyte
commitment factor during fetal development [60]. It
maintains white adipocyte identity by suppressing
EBF2/PPARγ-dependent Prdm16 induction [61].
Maternal obesity led to DNA hypomethylation at
Zfp423 and the increased gene expression in whole
fetal tissues from embryos, which results in increased
adipogenesis in the offspring at weaning and
increased susceptibility to obesity later in life [62].
Similar to this study, a global profiling study detected
DNA hypomethylation at Zfp423 promoter regions
in the adipose tissue from obese dams compared to
controls [63].
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Another protein involved in transgenerational
regulation is PPARγ, which is the master transcrip-
tion factor for both white and brown adipogenesis
and is involved in brown adipocyte development and
thermogenic gene regulation [64,65]. Offspring with
obese mothers have persistently lower PPARγ
expression due to higher epigenetic repression,
such as DNA hypermethylation and fewer active
histone markers, at the Pparg promoter region [66].
Follow-up studies are necessary to address whether
these DNA methylation and transcriptional changes
impact brown/beige adipose development in neo-
nates and later in life. In addition, more studies are
needed to determine whether this altered thermo-
genic fat biology and its associated metabolic effects
are truly transgenerational and whether DNA (de)
methylation is involved in that process.
Conclusions and future perspectives
Studies strongly suggest that DNA (de)methylation
plays a critical role in brown adipose development
and thermogenic gene regulation (summarized in
Figure 1). However, a deeper understanding is
needed before we can target them in the treatment
of obesity and related disorders. For example, what
is the role of DNA (de)methylation in regulating
‘browning’ and ‘whitening’ and how dynamically
are they regulated in response to various external
cues? Also, little is known about the putative inter-
action between DNA (de)methylation and other
epigenetic mechanisms in governing thermogenic
brown/beige adipogenesis and plasticity.
Furthermore, it’s crucial to investigate whether the
machinery is functionally implicated in thermo-
genic brown/beige adipose development and func-
tion in humans. In conclusion, elucidating the role
of DNA (de)methylation in brown and beige adi-
pose biology will shed light on effective therapeutic
interventions for obesity and obesity-related human
diseases.
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